Drug Shortage Report for SANDOZ RIVASTIGMINE

Last updated on 2019-04-10 History
Report ID 74710
Drug Identification Number 02324571
Brand name SANDOZ RIVASTIGMINE
Common or Proper name RIVASTIGMINE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) RIVASTIGMINE
Strength(s) 3MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 4X14/bl
ATC code N06DA
ATC description ANTI-DEMENTIA DRUGS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2019-01-23
Estimated end date 2019-03-18
Actual end date 2019-03-22
Shortage status Resolved
Updated date 2019-04-10
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2019-04-10 French Compare
v9 2019-04-10 English Compare
v8 2019-03-13 French Compare
v7 2019-03-13 English Compare
v6 2019-03-05 French Compare
v5 2019-03-05 English Compare
v4 2019-02-18 French Compare
v3 2019-02-18 English Compare
v2 2019-02-04 French Compare
v1 2019-02-04 English Compare